Published in Mol Clin Oncol on August 10, 2016
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol (1999) 9.92
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell (1994) 9.48
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest (2002) 3.36
Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A (2001) 2.98
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J (2001) 2.41
A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature (1996) 2.33
The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem (2001) 2.16
COP9 signalosome revisited: a novel mediator of protein degradation. Trends Cell Biol (2001) 1.80
COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem (1999) 1.57
JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep (2001) 1.45
Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer (2001) 1.44
Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci (2009) 1.34
Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett (2009) 1.22
Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro. Oncogene (2011) 1.12
Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res (2009) 1.06
Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin Cancer Res (2003) 1.05
Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma. Cancer Res (2012) 0.98
Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol Pharmacol (2009) 0.97
Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression. Int J Cancer (2003) 0.97
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. BMC Cancer (2008) 0.94
Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. Cancer Res (2006) 0.93
Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Lett (2008) 0.92
Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Ann Surg Oncol (2008) 0.89
Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma. Endocr J (2009) 0.88
Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Oncol Rep (2006) 0.86
Jab1 regulates Schwann cell proliferation and axonal sorting through p27. J Exp Med (2013) 0.85
Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer (2011) 0.85
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. Ann Oncol (2009) 0.85
Differential expression of forkhead box M1 and its downstream cyclin-dependent kinase inhibitors p27(kip1) and p21(waf1/cip1) in the diagnosis of pulmonary neuroendocrine tumours. Histopathology (2012) 0.85
Correlation between Skp2 expression and nodal metastasis in stage I and II oral squamous cell carcinomas. Oral Dis (2011) 0.83
Substituting threonine 187 with alanine in p27Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age. J Biol Chem (2015) 0.80
Gfer is a critical regulator of HSC proliferation. Cell Cycle (2011) 0.79
Inhibition of S-phase kinase-associated protein 2-mediated p27 degradation suppresses tumorigenesis and the progression of hepatocellular carcinoma. Mol Med Rep (2015) 0.78
[Changes in nutrition metabolism of lymphoma after treatment and the nutritional supports]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2014) 0.77
[Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma]. Beijing Da Xue Xue Bao (2014) 0.77